1
|
Brändli-Baiocco A, Balme E, Bruder M, Chandra S, Hellmann J, Hoenerhoff MJ, Kambara T, Landes C, Lenz B, Mense M, Rittinghausen S, Satoh H, Schorsch F, Seeliger F, Tanaka T, Tsuchitani M, Wojcinski Z, Rosol TJ. Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System. J Toxicol Pathol 2018; 31:1S-95S. [PMID: 30158740 PMCID: PMC6108091 DOI: 10.1293/tox.31.1s] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for
Lesions in Rats and Mice) Project (www.toxpath.org/inhand.asp) is a joint initiative among
the Societies of Toxicological Pathology from Europe (ESTP), Great Britain (BSTP), Japan
(JSTP) and North America (STP) to develop an internationally accepted nomenclature for
proliferative and nonproliferative lesions in laboratory animals. The purpose of this
publication is to provide a standardized nomenclature for classifying microscopic lesions
observed in the endocrine organs (pituitary gland, pineal gland, thyroid gland,
parathyroid glands, adrenal glands and pancreatic islets) of laboratory rats and mice,
with color photomicrographs illustrating examples of the lesions. The standardized
nomenclature presented in this document is also available electronically on the internet
(http://www.goreni.org/). Sources of material included histopathology databases from
government, academia, and industrial laboratories throughout the world. Content includes
spontaneous and aging lesions as well as lesions induced by exposure to test materials. A
widely accepted and utilized international harmonization of nomenclature for endocrine
lesions in laboratory animals will decrease confusion among regulatory and scientific
research organizations in different countries and provide a common language to increase
and enrich international exchanges of information among toxicologists and
pathologists.
Collapse
Affiliation(s)
- Annamaria Brändli-Baiocco
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
| | | | - Marc Bruder
- Compugen, Inc., Nonclinical Safety, South San Francisco, California, USA
| | | | | | - Mark J Hoenerhoff
- In Vivo Animal Core, Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan USA
| | | | - Christian Landes
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
| | - Barbara Lenz
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
| | | | | | - Hiroshi Satoh
- Iwate University, Faculty of Agriculture, Iwate, Japan
| | | | - Frank Seeliger
- AstraZeneca Pathology, Drug Safety and Metabolism, IMED Biotech Unit, Gothenburg, Sweden
| | - Takuji Tanaka
- Tohkai Cytopathology Institute, Cancer Research and Prevention, Gifu, Japan
| | - Minoru Tsuchitani
- LSI Medience Corporation, Nonclinical Research Center, Ibaraki, Japan
| | | | - Thomas J Rosol
- Ohio University, Department of Biomedical Sciences, Athens, Ohio, USA
| |
Collapse
|
2
|
Rath MF, Coon SL, Amaral FG, Weller JL, Møller M, Klein DC. Melatonin Synthesis: Acetylserotonin O-Methyltransferase (ASMT) Is Strongly Expressed in a Subpopulation of Pinealocytes in the Male Rat Pineal Gland. Endocrinology 2016; 157:2028-40. [PMID: 26950199 PMCID: PMC4870883 DOI: 10.1210/en.2015-1888] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The rat pineal gland has been extensively used in studies of melatonin synthesis. However, the cellular localization of melatonin synthesis in this species has not been investigated. Here we focus on the localization of melatonin synthesis using immunohistochemical methods to detect the last enzyme in melatonin synthesis, acetylserotonin O-methyltransferase (ASMT), and in situ hybridization techniques to study transcripts encoding ASMT and two other enzymes in melatonin synthesis, tryptophan hydroxylase (TPH)-1 and aralkylamine N-acetyltransferase. In sections of the rat pineal gland, marked cell-to-cell differences were found in ASMT immunostaining intensity and in the abundance of Tph1, Aanat, and Asmt transcripts. ASMT immunoreactivity was localized to the cytoplasm in pinealocytes in the parenchyma of the superficial pineal gland, and immunopositive pinealocytes were also detected in the pineal stalk and in the deep pineal gland. ASMT was found to inconsistently colocalize with S-antigen, a widely used pinealocyte marker; this colocalization was seen in cells throughout the pineal complex and also in displaced pinealocyte-like cells of the medial habenular nucleus. Inconsistent colocalization between ASMT and TPH protein was also detected in the pineal gland. ASMT protein was not detected in extraepithalamic parts of the central nervous system or in peripheral tissues. The findings in this report are of special interest because they provide reason to suspect that melatonin synthesis varies significantly among individual pinealocytes.
Collapse
Affiliation(s)
- Martin F Rath
- Department of Neuroscience and Pharmacology (M.F.R., M.M.), Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Section on Neuroendocrinology (M.F.R., S.L.C., F.G.A., J.L.W., D.C.K.), Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
| | - Steven L Coon
- Department of Neuroscience and Pharmacology (M.F.R., M.M.), Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Section on Neuroendocrinology (M.F.R., S.L.C., F.G.A., J.L.W., D.C.K.), Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
| | - Fernanda G Amaral
- Department of Neuroscience and Pharmacology (M.F.R., M.M.), Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Section on Neuroendocrinology (M.F.R., S.L.C., F.G.A., J.L.W., D.C.K.), Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
| | - Joan L Weller
- Department of Neuroscience and Pharmacology (M.F.R., M.M.), Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Section on Neuroendocrinology (M.F.R., S.L.C., F.G.A., J.L.W., D.C.K.), Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
| | - Morten Møller
- Department of Neuroscience and Pharmacology (M.F.R., M.M.), Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Section on Neuroendocrinology (M.F.R., S.L.C., F.G.A., J.L.W., D.C.K.), Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
| | - David C Klein
- Department of Neuroscience and Pharmacology (M.F.R., M.M.), Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Section on Neuroendocrinology (M.F.R., S.L.C., F.G.A., J.L.W., D.C.K.), Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
| |
Collapse
|
3
|
Long QY, Zhou J, Zhang XL, Cao JH. HOXB7 predicts poor clinical outcome in patients with advanced esophageal squamous cell cancer. Asian Pac J Cancer Prev 2014; 15:1563-6. [PMID: 24641368 DOI: 10.7314/apjcp.2014.15.4.1563] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Esophageal squamous cell carcinoma (ESCC) accounts for most esophageal cancer in Asia, and is the sixth common cause of cancer-related deaths worldwide. Previous studies indicated HOXB7 is overexpressed in ESCC tissues, but data on prognostic value are limited. METHODS A total of 76 advanced ESCC cases were investigated. Immunohistochemistry (IHC) was used to detect the expression levels of HOXB7 and Kaplan-Meier curves and Cox regression models to determine prognostic significance. Stratified analysis was also performed according to lymph node (LN) status. RESULTS Kaplan-Meier curve analysis indicated that HOXB7 positive patients had significantly shorter overall survival (OS) than HOXB7 negative patients. Multivariate analysis using the Cox proportional hazards model indicated only TNM stage and HOXB7 expression to be independent predictors of overall survival of advanced ESCC patients. HOXB7 indicated poor OS in both lymph node negative (LN?) and lymph node positive (LN+) patients. CONCLUSION HOXB7 predicts poor prognosis of advanced ESCC patients and can be applied as an independent prognostic predictor.
Collapse
Affiliation(s)
- Qing-Yun Long
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China E-mail :
| | | | | | | |
Collapse
|
4
|
Qiao G, Li Q, Peng G, Ma J, Fan H, Li Y. Similarity on neural stem cells and brain tumor stem cells in transgenic brain tumor mouse models. Neural Regen Res 2013; 8:2360-9. [PMID: 25206546 PMCID: PMC4146040 DOI: 10.3969/j.issn.1673-5374.2013.25.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2013] [Accepted: 08/25/2013] [Indexed: 11/29/2022] Open
Abstract
Although it is believed that glioma is derived from brain tumor stem cells, the source and molecular signal pathways of these cells are still unclear. In this study, we used stable doxycycline-inducible transgenic mouse brain tumor models (c-myc+/SV40Tag+/Tet-on+) to explore the malignant trans-formation potential of neural stem cells by observing the differences of neural stem cells and brain tumor stem cells in the tumor models. Results showed that chromosome instability occurred in brain tumor stem cells. The numbers of cytolysosomes and autophagosomes in brain tumor stem cells and induced neural stem cells were lower and the proliferative activity was obviously stronger than that in normal neural stem cells. Normal neural stem cells could differentiate into glial fibrillary acidic protein-positive and microtubule associated protein-2-positive cells, which were also negative for nestin. However, glial fibrillary acidic protein/nestin, microtubule associated protein-2/nestin, and glial fibrillary acidic protein/microtubule associated protein-2 double-positive cells were found in induced neural stem cells and brain tumor stem cells. Results indicate that induced neural stem cells are similar to brain tumor stem cells, and are possibly the source of brain tumor stem cells.
Collapse
Affiliation(s)
- Guanqun Qiao
- Department of Neurosurgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
| | - Qingquan Li
- Department of Neurosurgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
| | - Gang Peng
- Department of Neurosurgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
| | - Jun Ma
- Department of Neurosurgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
| | - Hongwei Fan
- Department of Pharmacology, the Third Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
| | - Yingbin Li
- Department of Neurosurgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
| |
Collapse
|
5
|
Abstract
A large variety of mass lesions have been reported in the region of the pineal gland. Pineal parenchymal tumors and germ cell tumors (GCTs) are especially characteristic of this region. Despite their rarity, a number of excellent studies on the cytogenetics and molecular genetics of pineal parenchymal tumors and pineal region GCTs have been published. These studies draw attention to a number of distinct genomic regions recurrently involved in the various subtypes of malignancies of the pineal gland. Outcomes for tumors in this location vary widely between patients and among differing histologies. Development of novel therapies for patients with poor prognoses will depend on the acquisition of a more detailed understanding of the molecular basis associated with the etiopathogenesis of these neoplasms. We review the literature on cytogenetics, familial syndromes, animal models and molecular genetics of pineal region neoplasms.
Collapse
Affiliation(s)
- M D Taylor
- Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Canada
| | | | | | | |
Collapse
|
6
|
Rutka JT, Taylor M, Mainprize T, Langlois A, Ivanchuk S, Mondal S, Dirks P. Molecular biology and neurosurgery in the third millennium. Neurosurgery 2000; 46:1034-51. [PMID: 10807235 DOI: 10.1097/00006123-200005000-00002] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
The application of techniques in molecular biology to human neurosurgical conditions has led to an increased understanding of disease processes that affect the brain and to novel forms of therapy that favorably modify the natural history of many of these conditions. Molecular strategies are currently being either used or sought for brain tumors, stroke, neurodegenerative diseases, vascular malformations, spinal degenerative diseases, and congenital malformations of the central nervous system. Considering that the structure of deoxyribonucleic acid was ascertained by Watson and Crick as recently as 1953, the progress that has been made to implement molecular medicine in clinical practice has been meteoric. More than 2000 patients have been treated in approved gene therapy trials throughout the world. Many of these patients have been treated for neurological diseases for which conventional medical therapies have been of limited utility. As part of this continuing series on advances in neurosurgery in the third millennium, we first reflect on the history of the nascent field of molecular biology. We then describe the powerful techniques that have evolved from knowledge in this field and have been used in many publications in Neurosurgery, particularly within the past decade. These methods include commonly used techniques such as advanced cytogenetics, differential display, microarray technology, molecular cell imaging, yeast two-hybrid assays, gene therapy, and stem cell utilization. We conclude with a description of the rapidly growing field of bioinformatics. Because the Human Genome Project will be completed within 5 years, providing a virtual blueprint of the human race, the next frontier (and perhaps our greatest challenge) will involve the development of the field of "proteomics," in which protein structure and function are determined from the deoxyribonucleic acid blueprint. It is our conviction that neurosurgeons will continue to be at the forefront of the treatment of patients with neurological diseases using molecular strategies, by performing essential research leading to increased understanding of diseases, by conducting carefully controlled studies to test the effects of treatments on disease processes, and by directly administering (by neurosurgical, endovascular, endoscopic, or stereotactic means) the treatments to patients.
Collapse
|
7
|
Miosge N, Hesse D, Götz W, Theuring F, Herken R. Localization of large-T oncoprotein during the embryonic and fetal development of transgenic mice. TERATOLOGY 1996; 54:278-83. [PMID: 9098921 DOI: 10.1002/(sici)1096-9926(199612)54:6<278::aid-tera2>3.0.co;2-v] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Oncoproteins are not only involved in the development of tumors but also play a role in physiological regulation in embryonic growth and differentiation. The mechanisms by which regulation is accomplished in embryonic stages differ from postnatal or adult stages. Oncoproteins responsible for tumors in the adult, i.e., products of proto-oncogenes, are prevented from causing tumors in the embryo. If oncogenes are introduced artificially into the embryo. will they be governed by the embryonic regulation described above? To answer this question we used transgenic mice in which the hybrid construct MSV-SV40-Large-T, composed of the Simian-Virus-Oncogene. Large-T with its SV40-promotor and the Moloney Murine Sarcoma Virus (MSV)-enhancer, had been integrated. Under the influence of large-T expression, these animals develop either brain or endocrine pancreas tumors. In the present investigation, we localised large-T expression during development of mouse embryos and fetuses. Interestingly, we saw large-T positive reactions in organ anlagen other than those that later develop tumors. We found large-T antigens in cartilage anlagen, e.g., in ribs and vertebrae, particularly in fetuses of days 14 to 17, and also in a variety of epithelial cells such as in the lung or the choroid plexus. Our results indicate that, as for proto-oncogene products, the effect of an artificially introduced transgenic oncogene product can also be regulated by embryonic cells.
Collapse
Affiliation(s)
- N Miosge
- Zentrum Anatomie, Abt. Histologie, Universität Göttingen, Germany
| | | | | | | | | |
Collapse
|
8
|
Aguzzi A, Brandner S, Isenmann S, Steinbach JP, Sure U. Transgenic and gene disruption techniques in the study of neurocarcinogenesis. Glia 1995; 15:348-64. [PMID: 8586469 DOI: 10.1002/glia.440150314] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Transgenic technologies have come of age, and the field of carcinogenesis has profited extensively from the availability of these methods. Both the inappropriate expression of dominant oncogenes in specific tissues and the ability to "knock out" tumor suppressor genes in mammalian organisms have enabled substantial advancements of our understanding of development and progression of the neoplastic phenotype. In the first part of this article, we review the most popular techniques for modification of the mammalian genome in vivo, i.e. microinjection of fertilized eggs, retrovirus-mediated gene transfer, and targeted gene deletion through homologous recombination. Subsequently, we attempt a critical evaluation of the available models of neurocarcinogenesis, and discuss their impact and future potential for the study of cancer in the nervous system.
Collapse
Affiliation(s)
- A Aguzzi
- Institute of Neuropathology, University Hospital of Zürich, Switzerland
| | | | | | | | | |
Collapse
|
9
|
Abstract
Several lines of transgenic mice developing eye malformations have been described in the literature and appear to be of increasing interest for the study of eye teratology in humans, since gene expression and regulation can be studied in the developing animal. Transgenic applications are briefly described here and an overview of existing transgenic mouse models carrying different eye abnormalities is given according to the major diagnosis (e.g., cataract, microphthalmia, anterior segment dysgenesis, retinal dysplasia). Interestingly, many transgenic models exhibit pathological findings similar to those observed in human pediatric ophthalmology. Unfortunately, detailed embryological studies in transgenic mice bearing congenital eye malformations are not available for all lines. Thus, the importance of creating further transgenic models to study the function of morphogenes and growth factors in eye development is also discussed.
Collapse
Affiliation(s)
- W Götz
- Department of Histology, University of Göttingen, Germany
| |
Collapse
|
10
|
Peterson DL, Sheridan PJ, Brown WE. Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 1994; 80:865-76. [PMID: 8169627 DOI: 10.3171/jns.1994.80.5.0865] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The scientific understanding of the biology of human brain tumors has advanced in large part through the use of animal models. For most of this century, investigators have been evaluating the inciting factors in brain tumor development, and applying this knowledge to direct tumor growth in laboratory animals. Virus-induced, carcinogen-induced, and transplant-based models have been vigorously investigated. As knowledge of the molecular biology of neoplasia has advanced, transgenic technology has been introduced. The authors review the development of animal models for brain tumor, and focus on the role of transgenic models in elucidating the complex process of central nervous system neoplasia.
Collapse
Affiliation(s)
- D L Peterson
- Division of Neurosurgery, University of Texas Health Science Center, San Antonio
| | | | | |
Collapse
|